Cognitive Stimulation in Older Adults With Alzheimer's Disease
Digital and Analogical Cognitive Stimulation in Older Adults With Alzheimer's Disease: Effects on Global Cognition, Well-being and Quality of Life Across Distinct Institutional and Sociogeographic Contexts
1 other identifier
interventional
514
1 country
39
Brief Summary
This multicentre study, employing a randomised controlled repeated measures experimental design, will be conducted in several Portuguese institutions that provide care and support services for older adults diagnosed with mild to moderate Alzheimer's disease (AD). The primary aim is to evaluate the effects of two distinct cognitive stimulation modalities (digital vs physical/analogue). The study will assess the impact of individual cognitive stimulation on multiple domains - specifically cognitive function (with an emphasis on memory and executive function), mood, and quality of life - and investigate how institutional and territorial characteristics influence these effects, considering geographical and organisational diversity as potential moderating factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
39 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2026
CompletedMarch 25, 2026
June 1, 2025
12 days
June 17, 2025
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Cognitive functioning assessed through Mini-Mental State Examination (MMSE)
Cognitive functioning assessed by the Mini-Mental State Examination (MMSE), a gold standard screening tool for assessing global cognitive function. Scores range from 0 to 30, with higher scores indicating better cognitive functioning.
Baseline
Change in cognitive functioning assessed through Mini-Mental State Examination (MMSE)
Change in cognitive functioning evaluated by the Mini-Mental State Examination (MMSE), a gold standard screening tool for assessing global cognitive function.Scores range from 0 to 30, with higher scores indicating better cognitive functioning.
12 weeks after the baseline
Change in cognitive functioning assessed through Mini-Mental State Examination (MMSE)
Change in cognitive functioning evaluated by the Mini-Mental State Examination (MMSE), a gold standard screening tool for assessing global cognitive function. Scores range from 0 to 30, with higher scores indicating better cognitive functioning.
24 weeks after the baseline
Cognitive functioning assessed through Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-COG)
Evaluates the severity of cognitive deficits in AD in the following domains: memory, orientation, language, praxis and constructive capacity. The total score in the Portuguese version of ADAS-Cog is composed of 11 subtests in the cognitive part and varies between 0 (better performance) and 68 points (worse performance), i.e., higher scores equals better performance.
Baseline
Change in cognitive functioning assessed through Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-COG)
Evaluates the severity of cognitive deficits in AD in the following domains: memory, orientation, language, praxis and constructive capacity. The total score in the Portuguese version of ADAS-Cog is composed of 11 subtests in the cognitive part and varies between 0 (better performance) and 68 points (worse performance), i.e., higher scores equals better performance.
12 weeks after the baseline
Change in cognitive functioning assessed through Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-COG)
Evaluates the severity of cognitive deficits in AD in the following domains: memory, orientation, language, praxis and constructive capacity. The total score in the Portuguese version of ADAS-Cog is composed of 11 subtests in the cognitive part and varies between 0 (better performance) and 68 points (worse performance), i.e., higher scores equals better performance.
24 weeks after the baseline
Memory function evaluated through Memory Alteration Test (MAT)
The MAT is used to assess memory function. It is an easy and quick instrument that assesses five memory domains: temporal orientation, encoding, semantic memory, free recall, and cued recall. Total scores range from 0 to 50, with higher scores indicating better memory. It has good psychometric properties and is highly sensitive to mild cognitive decline.
Baseline
Change in memory function evaluated through Memory Alteration Test (MAT)
The MAT is used to assess memory function. It is an easy and quick instrument that assesses five memory domains: temporal orientation, encoding, semantic memory, free recall, and cued recall. Total scores range from 0 to 50, with higher scores indicating better memory. It has good psychometric properties and is highly sensitive to mild cognitive decline.
12 weeks after the baseline
Change in memory function evaluated through Memory Alteration Test (MAT)
The MAT is used to assess memory function. It is an easy and quick instrument that assesses five memory domains: temporal orientation, encoding, semantic memory, free recall, and cued recall. Total scores range from 0 to 50, with higher scores indicating better memory. It has good psychometric properties and is highly sensitive to mild cognitive decline.
24 weeks after the baseline
Executive functions assessed through Frontal Assessment Battery (FAB)
FAB assesses executive functions such as abstract thinking, mental flexibility, motor programming, interference sensibility, inhibitory control and environmental independence. Scores range between 0 - 18 points with higher scores indicating better cognitive function.
Baseline
Change in executive functions assessed through Frontal Assessment Battery (FAB)
FAB assesses executive functions such as abstract thinking, mental flexibility, motor programming, interference sensibility, inhibitory control and environmental independence. Scores range between 0 - 18 points with higher scores indicating better cognitive function.
12 weeks after the baseline
Change in executive functions assessed through Frontal Assessment Battery (FAB)
FAB assesses executive functions such as abstract thinking, mental flexibility, motor programming, interference sensibility, inhibitory control and environmental independence. Scores range between 0 - 18 points with higher scores indicating better cognitive function.
24 weeks after the baseline
Secondary Outcomes (9)
Mood assessed through the Geriatric Depression Scale-15 (GDS-15)
Baseline
Change in mood assessed through the GDS-15
12 weeks after the baseline
Change in mood assessed through the GDS-15
24 weeks after the baseline
Anxiety symptomatology assessed through the Geriatric Anxiety Inventory (GAI)
Baseline
Change in anxiety symptomatology assessed through the GAI
12 weeks after the baseline
- +4 more secondary outcomes
Other Outcomes (2)
Sociodemographic, geographical and social information collected through the Sociodemographic, Geographical and Social Characteristics Questionnaire
Baseline
Adherence to the intervention and dropouts evaluated through a session form
up to 12 weeks after baseline
Study Arms (3)
Intervention group 1
EXPERIMENTALParticipants in the intervention group 1 will participate in two individual CS sessions per week for 12 weeks in addition to their treatment as usual. The sessions will include the same program in every participant site.
Intervention group 2
EXPERIMENTALParticipants in the intervention group 2 will participate in two individual CS sessions per week for 12 weeks in addition to their treatment as usual. The sessions will include the same program in every participant site.
Control group (No intervention)
NO INTERVENTIONParticipants in the control group will receive treatment as usual (TAU) at the site, following the activities specified in their individual care plans.
Interventions
Individual cognitive stimulation sessions will be delivered using RehaCom software, which provides adaptive, computerised exercises targeting specific cognitive domains.
Individual cognitive stimulation sessions will employ structured physical materials, specifically the 'Memories from North to South©' and 'Cognitive Domains' resources, applied on an alternating basis.
Eligibility Criteria
You may qualify if:
- Age 65 or older.
- Receive care/support services for at least three months.
- A diagnosis of probable AD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, text revision.
- Preserved communication skills.
- Native Portuguese speaker.
- Total scores between 10 and 26 points on the Mini Mental State Examination.
You may not qualify if:
- Cannot read and write.
- Significant sensory or physical limitations.
- Acute or chronic illness preventing participation.
- Severe communication impairment.
- Aggressive or disruptive behaviour.
- Recent initiation (within two months) of neuroleptics, antipsychotics, or other psychoactive medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (39)
AMITEI
Leiria, Leria, Portugal
Associação de Desenvolvimento Comunitário do Funchal - Garouta do Calhau
Funchal, Madeira, Portugal
Instituto S. João de Deus Funchal
Funchal, Madeira, Portugal
Associação Alzheimer Açores
Açores, Portugal
Santa Casa da Misericórdia da Horta
Açores, Portugal
Santa Casa da Misericórdia de Vila do Porto
Açores, Portugal
CASTIIS
Aveiro, Portugal
CEDIARA - Associação de Solidariedade Social de Ribeira de Fráguas
Aveiro, Portugal
Centro Apoio Social Mozelos
Aveiro, Portugal
Centro Social da Freguesia de Casal Comba
Aveiro, Portugal
O Jardim - Centro de Solidariedade Social de Canedo
Aveiro, Portugal
Santa Casa da Misericórdia de Espinho
Aveiro, Portugal
Santa Casa da Misericórdia de Ovar
Aveiro, Portugal
Patronato de Santo António - Lar D. José do Patrocínio Dias
Beja, Portugal
Santa Casa da Misericórdia de Ferreira do Alentejo
Beja, Portugal
Centro Social do Vale do Homem Casa da Alegria
Braga, Portugal
Santa Casa da Misericórdia de Mirandela
Bragança, Portugal
Residência Sénior DON ANTÓNIO - Hilário & Pereira
Castelo Branco, Portugal
Santa Casa da Misericórdia da Soalheira
Castelo Branco, Portugal
Santa Casa da Misericórdia de Vila Velha de Rodão
Castelo Branco, Portugal
Associação Cultural Recreativa e Social de Samuel
Coimbra, Portugal
Santa Casa da Misericórdia de Montemor-o-Novo
Evora, Portugal
Santa Casa da Misericórdia de Vila Real de Santo António
Faro, Portugal
Fundação João Bento Raimundo
Guarda, Portugal
Santa Casa da Misericórdia de Figueira de Castelo Rodrigo
Guarda, Portugal
Santa Casa da Misericórdia de Alcobaça
Leiria, Portugal
Santa Casa da Misericórdia de Alvaiázere
Leiria, Portugal
Santa Casa da Misericórdia de Alvorge
Leiria, Portugal
Associação Casapiana de Solidariedade
Lisbon, Portugal
Associação de Socorros da Freguesia de Turcifal
Lisbon, Portugal
Centro Social Paroquial de Moita dos Ferreiros
Lisbon, Portugal
Santa Casa da Misericórdia de Lisboa - Espaço ComVida
Lisbon, Portugal
Santa Casa da Misericórdia de Campo Maior
Portalegre, Portugal
Santa Casa da Misericórdia de Gaia - ERPI José Tavares Bastos
Porto, Portugal
Quinta de Santa Ana RS
Viana do Castelo, Portugal
Santa Casa da Misericórdia de Caminha
Viana do Castelo, Portugal
Santa Casa da Misericórdia de Ponte de Lima
Viana do Castelo, Portugal
Associação de Solidariedade Social do Alto Paiva
Viseu, Portugal
Associação de Solidariedade Social e Recreativa de Nespereira
Viseu, Portugal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susana I. Justo Henriques, PhD
Polytechnic University of Beja
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2025
First Posted
June 27, 2025
Study Start
September 1, 2025
Primary Completion
September 13, 2025
Study Completion
March 13, 2026
Last Updated
March 25, 2026
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share